Bioprosthetics Market Size, Share & Trends Analysis Report By Product (Allograft, Xenograft), By Application (Cardiovascular, Plastic Surgery & Wound Healing), By Region, And Segment Forecasts, 2025 - 2030

Bioprosthetics Market Growth & Trends

The global bioprosthetics market size is estimated to reach USD 7.64 billion by 2030, registering a CAGR of 4.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Bioprosthetics Market Report Highlights

  • The allograft product segment dominated the market and accounted for a share of 69.6% in 2024, owing to the increasing geriatric population and advancement in allograft procedures.
  • By application, the plastic surgery and wound healing segment is expected to witness significant CAGR growth over the forecast period, owing to rising demand for minimally invasive surgery and technological advancement.
  • Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments.
  • The North American bioprosthetics market held a dominant position with a revenue share of 37.1% in 2024, owing to the increasing prevalence of cardiovascular diseases and developed healthcare infrastructure.
  • For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Endoscopic Submucosal Dissection Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Bioprosthetics: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. Bioprosthetics Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Bioprosthetics Market, by Product, 2018 to 2030
4.5. Allograft
4.5.1. Allograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Xenograft
4.6.1. Xenograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Bioprosthetics Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Bioprosthetics Market, by Application, 2018 to 2030
5.5. Cardiovascular
5.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Plastic surgery & wound healing
5.6.1. Plastic surgery & wound healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Bioprosthetics Market Segment Analysis, By Region, 2018- 2030 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Bioprosthetics Market Share by Region, 2024 & 2030:
6.5. North America
6.5.1. North America bioprosthetics market, 2018 - 2030 (USD Million)
6.5.2. U.S.
6.5.2.1. U.S. bioprosthetics market, 2018 - 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Canada bioprosthetics market, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Mexico bioprosthetics market, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. Europe bioprosthetics market, 2018 - 2030 (USD Million)
6.6.2. UK
6.6.2.1. UK bioprosthetics market, 2018 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Germany bioprosthetics market, 2018 - 2030 (USD Million)
6.6.4. France
6.6.4.1. France bioprosthetics market, 2018 - 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Italy bioprosthetics market, 2018 - 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Spain bioprosthetics market, 2018 - 2030 (USD Million)
6.6.7. Norway
6.6.7.1. Norway bioprosthetics market, 2018 - 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Sweden bioprosthetics market, 2018 - 2030 (USD Million)
6.6.9. Denmark
6.6.9.1. Denmark bioprosthetics market, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Japan bioprosthetics market, 2018 - 2030 (USD Million)
6.7.2. China
6.7.2.1. China bioprosthetics market, 2018 - 2030 (USD Million)
6.7.3. India
6.7.3.1. India bioprosthetics market, 2018 - 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Australia bioprosthetics market, 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. South Korea bioprosthetics market, 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Thailand bioprosthetics market, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Brazil bioprosthetics market, 2018 - 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Argentina bioprosthetics market, 2018 - 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. South Africa bioprosthetics market, 2018 - 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Saudi Arabia bioprosthetics market, 2018 - 2030 (USD Million)
6.9.3. UAE
6.9.3.1. UAE bioprosthetics market, 2018 - 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Kuwait bioprosthetics market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. LeMaitre Vascular, Inc.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Braile Biomédica
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Medtronic
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Labcor Laboratories Ltda
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Rua Life Sciences Plc (Aortech International Plc.)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. LivaNova PLC (Sorin Group)
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Organogenesis Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Humacyte Global, Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Johnson & Johnson (Ethicon, Inc.)
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Artivion, Inc. (CryoLife, Inc.)
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Abbott (St. Jude Medical, Inc.)
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Edwards Lifesciences Corporation
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. JenaValve
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings